Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.71%)
As of: Oct 21, 2026 · 10:22 AM EDT

Immuron (IMRN) Research & Development (2023 - 2024)

Updated

Immuron (IMRN) posted Research & Development of -$1.93 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Research & Development (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported Research & Development for 12 fiscal years.

  • Annual Research & Development has run from a low of -$3.6 million in FY2025 to a high of $2.65 million in FY2023 over five years.
  • Business Quant data shows IMRN's Research & Development at -$3.6 million in FY2025, -$53,755 in FY2024, $2.65 million in FY2023 (+74.4%) and $1.52 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 3.65 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 2.34 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 4.05 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 1.76 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 2.81 Bn
10 Immuron 7.22 Mn -9.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.52 Mn
Sep 9, 2024 -35,818.58
Dec 31, 2023 -16,874.62
API Access

Immuron Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IMRN&period=max&api_key=YOUR_API_KEY